Editorial: Axonopathy in Neurodegenerative Disease

Affiliations

¹ The Jackson Laboratory, Bar Harbor, ME, United States.
² Department of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, OH, United States.

Editorial

Robert W Burgess et al. Front Neurosci. 2018.

. 2018 Oct 23:12:769.

doi: 10.3389/fnins.2018.00769. eCollection 2018.

¹ The Jackson Laboratory, Bar Harbor, ME, United States.
² Department of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, OH, United States.

No abstract available

Keywords: axon degeneration; chemotherapy induced neuropathy; glaucoma; mitochondrial dysfuncion; neuropathy.

Comment on

1. Argyriou A. A., Kyritsis A. P., Makatsoris T., Kalofonos H. P. (2014). Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature. Cancer Manag. Res. 6, 135–147. 10.2147/CMAR.S44261 - DOI - PMC - PubMed
1. Cavanagh J. B. (1964). The significance of the “dying back” process in experimental and human neurological disease. Int. Rev. Exp. Pathol. 3, 219–267. - PubMed
1. Conforti L., Adalbert R., Coleman M. P. (2007). Neuronal death: where does the end begin? Trends Neurosci. 30, 159–166. 10.1016/j.tins.2007.02.004 - DOI - PubMed
1. Fischer L. R., Culver D. G., Tennant P., Davis A. A., Wang M., Castellano-Sanchez A., et al. . (2004). Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185, 232–240. 10.1016/j.expneurol.2003.10.004 - DOI - PubMed
1. Mack T. G., Reiner M., Beirowski B., Mi W., Emanuelli M., Wagner D., et al. . (2001). Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci. 4, 1199–1206. 10.1038/nn770 - DOI - PubMed